Ms Brennan said cervical cancer patients were dealing with enough on a daily basis and needed the government to push through a deal now for access to Pembro.

Mr Kelly said that pre-testing showed Pembro benefited certain women and had already been sanctioned in the United States.

From a drug view, this was a “last chance” for some patients, he said.

The government has said Pembro has not been EU approved but it has asked health chiefs to look at a possible scheme for equal access to the drug.

“We need equity of access to the Pembro drug which has had such a dramatic impact on Vicky's health and her life. We need this for all women. Women who across the country who need this drug haven't really the time for this to go on for very long,” added Mr Kelly.

Get the negotiations out of the way, get the same scheme that is in place for Vicky and ensure that Aine and Tracey and other women affected will get access to this drug immediately.

This is a life-changing drug, this extends women's lives, it changes their lives.

It was unacceptable that women affected needed to go around fundraising for the drug, Mr Kelly said.

It is understood that the government has asked the National Centre for Pharmacoeconomics, which tests medicines, to look at extending access to Pembro.